What is the recommended valacyclovir dosing regimen for cutaneous herpes simplex virus infection in an otherwise healthy adult?

Valacyclovir Dosing for Cutaneous HSV

For cutaneous HSV infection in otherwise healthy adults, valacyclovir 1 gram orally twice daily is the recommended dose 1.

Dosing by Clinical Presentation

Mucocutaneous HSV (Non-Genital)

• Standard dose: 1 gram orally twice daily for 5-10 days 2
• This is FDA-approved for adults and adolescents with mucocutaneous HSV 1
• Treatment duration depends on lesion severity and healing progress

Orolabial Herpes (Cold Sores)

• Short-course option: 2 grams orally twice daily for 1 day (two doses 12 hours apart) 3
• This abbreviated regimen is specifically FDA-approved for cold sores in patients ≥12 years 3
• Must be initiated at earliest symptom (tingling, itching, burning) 3
• Research supports that approximately 42-47% of episodes abort with this regimen, particularly when started during prodrome 4

Genital Herpes (for comparison)

• Episodic treatment: 500 mg orally twice daily for 3-5 days 5, 6
• First episode: May require higher doses or longer duration (up to 10 days)

Key Clinical Considerations

Severity-based approach:

• Mild to moderate cutaneous lesions: Start with oral valacyclovir 1 gram twice daily
• Severe mucocutaneous disease: Consider IV acyclovir 5-10 mg/kg every 8 hours initially, then transition to oral valacyclovir once lesions begin regressing 1, 2

Treatment initiation timing is critical:

• Greatest benefit occurs when therapy starts during prodrome or within 6 hours of first symptoms 4
• Approximately 50% of episodes abort when treatment begins this early 4

Important Caveats

Renal dosing adjustments are mandatory:

• CrCl 30-49 mL/min: No reduction needed for short courses; 500 mg every 24 hours for longer treatment
• CrCl 10-29 mL/min: 500 mg every 24 hours
• CrCl <10 mL/min: 500 mg every 24 hours
• Hemodialysis: Dose after dialysis session 3

Population-specific warnings:

• Elderly patients have higher risk of CNS and renal adverse events; ensure adequate hydration 3
• The 2-gram twice daily regimen for cold sores has not been extensively studied beyond facial lesions
• HIV-infected patients may require longer treatment courses (up to 14 days) and should not use abbreviated regimens 2

Common pitfall: Do not use the abbreviated 1-day regimen (2 grams twice daily) for non-facial cutaneous HSV or for immunocompromised patients—this is only validated for immunocompetent patients with orolabial herpes 3.

Treatment failure considerations:

• If lesions don't improve within 7-10 days, suspect acyclovir resistance
• Obtain viral culture with susceptibility testing 2
• Acyclovir-resistant HSV requires IV foscarnet 40 mg/kg every 8 hours 1